Aggressive Kaposi’s Sarcoma Associated With Golimumab Therapy

References (4)

1. Hamzaoui L, Kilani H, Bouassida M, Mahmoudi M, Chalbi E, Siai K, et al. Iatrogenic colorectal Kaposi sarcoma complicating a refractory ulcerative colitis in a human immunodeficiency negative-virus patient. Pan Afr Med J 2013;15:154 Bret J, Hernandez J, Aquilina C, Zabraniecki L, Fournie B. Kaposi's disease in a patient on adalimumab for rheumatoid arthritis. Joint Bone Spine 2009;76:721-2.
2. Amadu V, Satta R, Montesu MA, Cottoni F. Kaposi's sarcoma associated with treatment with adalimumab. Dermatol Ther 2012;25:619-20. Martínez-Martínez ML, Pérez-García LJ, EscarioTravesedo E, Ribera-Vaquerizo PA. Kaposi sarcoma associated with infliximab treatment. Actas Dermosifiliogr 2010;101:462-4.
3. Ursini F, Naty S, Mazzei V, Spagnolo F, Grembiale RD. Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab. Int Immunopharmacol 2010;10:827-8.
4. Cohen CD, Horster S, Sander CA, Bogner JR. Kaposi's sarcoma associated with tumour necrosis factor alpha neutralising therapy. Ann Rheum Dis 2003;62:684. Margolis D, Bilker W, Hennessy S, Vittorio C, Santanna J, Strom BL. The risk of malignancy associated with psoriasis. Arch Dermatol 2001;137:778-83. Quéreux G, Renaut JJ, Peuvrel L, Knol AC, Brocard A, Dréno B. Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: role of immunosuppressants. Acta Derm Venereol 2010;90:616-20.